Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Domain, Rusnano invest in ReVision

July 30, 2013 12:09 AM UTC

Domain Associates and Rusnano, the state-funded $10 billion Russian fund, made their fifth investment under a 2012 investment partnership in Domain portfolio company ReVision Optics Inc. (Lake Forest, Calif.). The ophthalmic device company raised $55 million in an undisclosed equity round from existing investors Canaan Partners; ProQuest Investments; InterWest Partner; and Domain, as well as new investors Rusnano and the Johnson & Johnson Development Corp. venture arm of Johnson & Johnson (NYSE:JNJ). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article